Dr. Carsten Ehrhardt, Trinity College Dublin - Qepler Summits And Conferences

Dr. Carsten Ehrhardt

Professor in Pharmaceutics and Biopharmaceutics
Trinity College Dublin
Trinity College Dublin, the University of Dublin, Ireland

Carsten Ehrhardt is Professor in Pharmaceutics at the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin.

In addition, he is holding an Adjunct Professorship at the School of Pharmacy, University of Southern California.

He was elected Fellow of Trinity College Dublin in 2013.

Carsten obtained his Ph.D. in Biopharmaceutics from Saarland University in 2003.

His research is focused on lung drug disposition, pulmonary epithelial transport and molecular origins of airways disease.

He has edited 1 book and (co-)authored 91 peer-reviewed publications and more than 230 abstracts and conference proceedings.

Carsten has given over 120 invited oral presentations.

He is the proud recipient of honours and awards from DPhG, APS and Galenus Foundation.

Carsten actively serves on the Editorial Boards of the American Journal of Physiology - Lung Cellular and Molecular Physiology, European Journal of Pharmaceutics and Biopharmaceutics, European Journal of Pharmaceuticals Sciences, Journal of Aerosol Medicine and Pulmonary Drug Delivery and Journal of Pharmaceutical Sciences.

Related Sessions:

Inhaled Drug Delivery
Summit 2019

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 23 May 2019
  • Berlin, DE
  • Pharma
Day 1: Thursday, 23 May 2019
CASE STUDY: Inhaled antimicrobials: Current strategies and future challenges.
  • Evaluation of inhaled antimicrobials in CF, bronchiectasis, COPD and VAP
  • Available drugs and compounds in the pipeline
  • Formulations and and devices for inhaled antimicrobial delivery
View Details

2nd Annual Inhaled
Drug Delivery Summit 2021

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 05 Aug 2021
  • Virtual,
  • Pharma
Day 1: Thursday, 05 August 2021
CASE STUDY: Using the inhalation route to delivery drugs to the systemic circulation.
  • Advantages and limitation of the pulmonary route to the systemic circulation
  • Requirements for distal lung aerosol delivery
  • Medicines for systemic inhalation therapy on the market and in the development pipeline
  • Critical assessment of factors governing the success (or failure) of systemically inhaled products
View Details